Dr. Omar Hassan, MD (Internal Medicine)

Dr. Omar Hassan, MD (Internal Medicine)

Board Certifications: Internal Medicine (1995); Geriatric Medicine (2000); Hospital Medicine (2008)

Experience: 30 years | Location: Dubai, UAE

Education: MBBS, Cairo University Faculty of Medicine (1992); MD Internal Medicine, Ain Shams University (1995); Advanced Training in Hospital Medicine, Cleveland Clinic (2007)

Dr. Omar Hassan is a highly distinguished internist with an exceptional 30-year career managing complex chronic diseases and training generations of physicians across the Middle East. As one of Dubai's most respected senior physicians, Dr. Hassan has treated over 35,000 patients and serves as a mentor and clinical educator to hundreds of medical professionals.

After completing his MD in Internal Medicine with academic distinction in Egypt, Dr. Hassan moved to the Gulf region where he pioneered comprehensive chronic disease management programs integrating evidence-based protocols with patient education and lifestyle modification. His systematic approach to hypertension management—combining medication optimization, dietary counseling, and stress reduction—has consistently achieved blood pressure control rates exceeding 85%, well above international benchmarks.

Dr. Hassan specializes in managing medically complex patients with multiple comorbidities, a population increasingly common in modern medicine. His expertise spans diabetes, cardiovascular disease, chronic kidney disease, COPD, and polypharmacy management in elderly patients. He has developed clinical pathways for hospitalists managing acute decompensations of chronic illnesses, reducing hospital readmission rates and improving patient outcomes.

As a prolific medical educator, Dr. Hassan has authored multiple continuing medical education (CME) guides on topics including hypertension management, heart failure treatment, diabetes complications, and anticoagulation therapy. His CME courses have been completed by over 5,000 physicians across the Middle East and North Africa region. He regularly lectures at Dubai Medical College and serves as an examiner for the Arab Board of Medical Specializations.

At My Medicine Advisor, Dr. Hassan provides senior clinical oversight for internal medicine content, ensuring recommendations reflect real-world clinical experience and evidence-based best practices. His three decades of frontline experience inform practical, patient-centered health guidance.

Professional Affiliations: American College of Physicians (Fellow); Emirates Medical Association; Society of Hospital Medicine; European Society of Internal Medicine

Publications: 7 CME course curricula

Awards: Lifetime Achievement Award, Emirates Medical Association (2024); Excellence in Medical Education Award, Dubai Health Authority (2020)

Languages: Arabic; English; French

Knows about: Chronic disease management; hypertension and blood pressure control; diabetes mellitus complications; heart failure management; geriatric medicine and polypharmacy; hospital medicine and acute care; preventive internal medicine; medical education and mentorship

Small cell lung cancer anatomy illustration showing lung tumor cells under magnification

Small Cell Lung Cancer Survival Rates in 2026: What Stage-by-Stage Data Really Means & How New Immunotherapy Is Changing Outcomes

Small cell lung cancer survival rates range from 3% to 27% by stage — but 2026 immunotherapy breakthroughs are extending lives beyond what those numbers suggest. This guide explains every stage, what the survival data actually means for individual patients, and the newest treatment combinations giving oncologists real hope.